90 likes | 198 Views
Parkinson’s Disease. Introduction. Second most common human neurodegenerative disorder. Prevalence of 1 out 272 in U.S. Increases to 4 to 5% for ages 85 and over. Degeneration of dopaminergic neurons in the substantia nigra. Wrote an Essay on the “Shaking Palsy.”. Symptoms.
E N D
Introduction Second most common human neurodegenerative disorder. Prevalence of 1 out 272 in U.S. Increases to 4 to 5% for ages 85 and over. Degeneration of dopaminergic neurons in the substantianigra.
Symptoms Four Cardinal Signs T remor R igidity A kinesian and bradykinesia P ostural instability
Pathogenesis Four theories are given: • Oxidative damage • Environmental toxins • Genetic mutations (LRRK2, PARK2, PARK7, PINK1, SNCA and other unidentified genes) • Accelerated aging
Diagnosis • No definitive tests for PD. PET scans can aid to determine levels of dopamine. • Difficult to diagnose, many symptoms shared with other disorders. • Medical history and neurological tests are conducted to diagnose. • Usually, if two of the cardinal symptoms are present.
Treatment • Physical Therapy • Drug Therapy • Surgery
Role of Biotechnology in Parkinson’s disease: • Stem cell therapy • Gene therapy • Diagnostic marker